A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations needed to rule out other conditions like depression or schizophrenia. With ...

Shares of Atai Life Sciences hit a two-year high after the company announced $50 million in private-placement financing and disclosed positive results for a study of a depression drug it has interests ...

The face is a primary interface between emotional state and physical expression. It is how mood communicates itself to t ...

Following a Mediterranean diet could help prevent depression, groundbreaking new psychiatric research suggests.

The National Hurricane Center will be watching a frontal boundary that is expected to stall near the Gulf Coast this week.

Atai Life Sciences’ psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the ...

The National Hurricane Center is monitoring a disturbance expected to stall over or near Florida, which could affect your ...

Retail, food service, media, and healthcare jobs are linked to higher depression and distress rates than other job types, a ...

Advocates are nervous, because Wisconsin's status as a purple state means it could swing one way or the other after any major ...

Atai Life Sciences NV shares climbed after a psychedelic nasal spray from Beckley Psytech Ltd, the company it plans to ...

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of ...